A detailed history of Prudential Financial Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Prudential Financial Inc holds 16,000 shares of ROIV stock, worth $185,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,000
Previous 13,320 20.12%
Holding current value
$185,120
Previous $140,000 31.43%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.17 - $12.5 $27,255 - $33,500
2,680 Added 20.12%
16,000 $184,000
Q2 2024

Aug 13, 2024

BUY
$10.36 - $11.74 $725 - $821
70 Added 0.53%
13,320 $140,000
Q1 2024

May 14, 2024

BUY
$9.87 - $11.8 $130,777 - $156,350
13,250 New
13,250 $139,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.